Reference Values and Clinical Screening Test of Diffuse Noxious Inhibitory Controls (DNIC) Using Deep Learning and Artificial Intelligence
Sponsor: Université de Sherbrooke
Trial Details
| Condition | Chronic Pain |
| Intervention | Conditioned pain modulation test |
| Status | Suspended |
| Participants | 244 |
| Est. Completion | 1 Dec 2028 |
| Last Updated | 28 May 2026 |
Primary Outcome
Conditioned pain modulation (CPM) profiles; Temporal summation profiles
Eligibility Criteria
Inclusion Criteria
Healthy participants Inclusion Criteria: * 18-79 years old * No chronic pain * Able to provide consent Exclusion Criteria: * Cardiovascular disease (arrhythmia, cerebrovascular accident, infarction...) * Raynaud syndrome * Severe psychiatric disease (dementia, schizophrenia, psychosis, major depression) * Injuries or loss sensitivity to their forearms or hands * Pregnant women or in post-partum period (\<1 year) Participants with chronic pain Inclusion Criteria: * 18-79 years old * Chronic pain (chronic pain is defined by any regular pain for more than 6 months) * Able to provide consent Exclusion Criteria: * Cardiovascular disease (arrhythmia, cerebrovascular accident, infarction...) * Raynaud syndrome * Severe psychiatric disease (dementia, schizophrenia, psychosis, major depression) * Injuries or loss sensitivity to their forearms or hands * Pregnant women or in post-partum period (\<1 year) * Chronic pain caused by cancer or migraine
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service